NASDAQ:BEAM

Beam Therapeutics Earning Date

USA |NASDAQ |USD

BEAM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.74 $-1.23 $-0.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $7.19M $6.00K $6.00K

Beam Therapeutics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

BEAM Earnings Date & History Chart

BEAM Earnings & Revenue Forecast

BEAM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.94 $-1.03 $-0.77
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-6.24 $-6.90 $-5.48
Dec 2022 9 $-3.79 $-4.47 $-3.19

BEAM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.95 $-0.91 $-0.77
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-6.25 $-6.06 $-5.11
Dec 2022 0 / 0 $-3.76 $-3.60 $-3.45

BEAM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $940.00K $0.00 $7.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $1.89M $0.00 $15.01M
Dec 2022 9 $7.23M $0.00 $30.00M

BEAM Earnings Date & Revenue History

BEAM Earnings History

|
Show More
Show More

BEAM Revenue History

|
Show More
Show More

Beam Therapeutics Next Earnings Date & Report

BEAM Next Earnings Date & Report Preview: Sep 2021 (FQ)

BEAM's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 9 analysts, the average EPS estimation for Beam Therapeutics's next quarterly earnings is $-0.74, with a low EPS estimation of $-0.97, and a high estimation of $-0.15.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.72, the last 2 month trend is $-0.68, and the 3 month trend is $-0.74.

Based on 6 analysts, the average revenue estimation is $7.19M, with a low revenue estimation of $0.00, and a high estimation of $50.00M.

Beam Therapeutics Previous Earnings Dates & Reports

BEAM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Beam Therapeutics's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

BEAM's earnings per share (EPS) was $-1.23, missing the consensus analysts forecast of $-0.74 by -66.82%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -63.28%, and lower than the same period a year before (Jun 2020) by 78.26%.

Revenues were $6.00K.

The company reported a net income of $-76.25M.

Free cash flow for the quarter was $-48.71M , compared to $-50.06M last quarter and $-25.20M a year before.

BEAM ended the quarter with $142.65M in total debt, an increase of 4.43% compared to the previous quarter, and an increase of 2063.97% compared to the same quarter a year before.

BEAM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Beam Therapeutics's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

BEAM's earnings per share (EPS) was $-4.10, missing the consensus analysts forecast of $-3.01 by 36.21% , and lower than the previous year's EPS (Dec 2019) by 1071.43%.

Revenues were $24.00K, better than the forecast of $10.00K by 140.00%, and up by 33.33% from previous year's revenue.

The company reported a net income of $-194.59M.

Beam Therapeutics reported a free cash flow of $-112.10M for its fiscal year, compared to $-84.52M a year ago.

The company ended the fiscal year with $11.63M in total debt, an increase of 15.71% compared to the previous year.